About this trial
The QUAD-HF registry is an observational study that would enroll patients in the United Kingdom, who have been newly diagnosed with heart failure and a left ventricular ejection fraction \<50%. We plan to assess clinical outcomes in these patients, such as hospitalization and death, in relation to their diagnosis, implementation of guidelines and type of treatments these patients have received.
Eligibility criteria
Qualifiers
Age >18 years
Newly diagnosed Heart Failure with a Left Ventricular Ejection Fraction <50% (≤12 Weeks prior to enrolment).
Able and willing to consent.
Disqualifiers
LVEF 50% or more at time of diagnosis
Palliative care
Unable or unwilling to give consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Mid and South Essex NHS Foundation Trust
Lead sponsor
Anglia Ruskin University
Collaborator
British Society for Heart Failure
Collaborator